Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | SVP, Chief Ent. Transf. Ofc. | August 01, 2024 | August 05, 2024 |
| DuPont de Nemours, Inc.DD · Entity 3297 | SVP, CIO | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date August 01, 2024 · Filed August 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,837.1789 |
Reported balance
After 2024-08-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-08-01 · Tax withholding · Disposed 453 · Balance 45,837.1789 F1: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2: Includes directly owned shares, restricted stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
F2: Includes directly owned shares, restricted stock units and dividend equivalent units.
DuPont de Nemours, Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,446.1375 |
Ending reported balance
After 2026-02-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 5,158 · Balance 13,251.1375 Row 2 · 2026-02-21 · Tax withholding · Disposed 805 · Balance 12,446.1375 F1: Taxes withheld on lapsed RSUs and associated dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Taxes withheld on lapsed RSUs and associated dividend equivalent units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2026 Filed Feb 24, 2026 22:03 UTC | DuPont de Nemours, Inc. DD · Entity 3297 | Tax withholdingCommon Stock | 805 | $50.36 | $40,539.80 |
DisclosureSEC source: 0001628280-26-011192 · wk-form4_1771970625.xml · nonDerivative · entry 2 Abbott Matthew S · CIK 0001786056 · SVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,446.1375 F1 · shares: Taxes withheld on lapsed RSUs and associated dividend equivalent units. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:03 UTC | DuPont de Nemours, Inc. DD · Entity 3297 | GrantCommon Stock | 5,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011192 · wk-form4_1771970625.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · SVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,251.1375 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:46 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 453 | $23.31 | $10,559.43 |
DisclosureSEC source: 0001062993-24-014434 · form4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · SVP, Chief Ent. Transf. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,837.1789 F1 · kind: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 32,879 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001062993-24-009870 · form4.xml · derivative · entry 3 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,879 Underlying: Common Stock · 32,879 shares Expires 2034-05-08 F4 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 31,614 | $0.00 Strike: $27.50 | $0.00 |
DisclosureSEC source: 0001062993-24-009870 · form4.xml · derivative · entry 2 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,614 Underlying: Common Stock · 31,614 shares Expires 2034-05-08 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 11,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009870 · form4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,106.2245 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:06 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,039 | $28.88 | $58,886.32 |
DisclosureSEC source: 0001062993-24-007444 · form4.xml · nonDerivative · entry 2 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,288.2245 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:06 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-007444 · form4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,327.2245 F1 · shares: Vesting of performance share units (PSUs). F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:01 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 4,415 | $20.78 | $91,743.70 |
DisclosureSEC source: 0001062993-24-005603 · form4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,931.4001 F1 · kind: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 21:24 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044505 · doc4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · SVP, Chief Enterprise Transfor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,044.295 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on August 1, 2024. F2 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:46 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,912 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001209191-23-035921 · doc4.xml · derivative · entry 3 Abbott Matthew S · CIK 0001786056 · SVP, Chief Enterprise Transfor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,912 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:46 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 8,912 | $34.20 | $304,790.40 |
DisclosureSEC source: 0001209191-23-035921 · doc4.xml · nonDerivative · entry 2 Abbott Matthew S · CIK 0001786056 · SVP, Chief Enterprise Transfor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,869.1243 F2 · price: Shares were sold in multiple transactions at a price of $34.20. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:46 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 8,912 | $14.43 | $128,600.16 |
DisclosureSEC source: 0001209191-23-035921 · doc4.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · SVP, Chief Enterprise Transfor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,781.1243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| May 27, 2021 Filed May 27, 2021 21:25 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,913 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-21-000032 · primary_doc.xml · derivative · entry 3 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,824 Underlying: Common Stock · 8,913 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 27, 2021 21:25 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 8,913 | $35.61 | $317,391.93 |
DisclosureSEC source: 0001627223-21-000032 · primary_doc.xml · nonDerivative · entry 2 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,961.6481 F2 · price: Shares were sold in multiple transactions at prices ranging from $35.60 to $35.625. F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| May 27, 2021 Filed May 27, 2021 21:25 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 8,913 | $14.43 | $128,614.59 |
DisclosureSEC source: 0001627223-21-000032 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,874.6481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:40 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 12,269 | $0.00 Strike: $24.01 | $0.00 |
DisclosureSEC source: 0001627223-21-000019 · primary_doc.xml · derivative · entry 4 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,269 Underlying: Common Stock · 12,269 shares Expires 2031-03-01 F5 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:40 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 10,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000019 · primary_doc.xml · nonDerivative · entry 3 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,778.0672 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on March 1, 2024. F4 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:40 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 1,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000019 · primary_doc.xml · nonDerivative · entry 2 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,366.0672 F2 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022. F4 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:40 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 581 | $24.01 | $13,949.81 |
DisclosureSEC source: 0001627223-21-000019 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,117.0672 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F4 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:22 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 26,737 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000015 · primary_doc.xml · derivative · entry 2 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,737 Underlying: Common Stock · 26,737 shares Expires 2030-03-02 F2 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:22 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 17,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000015 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,843 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on March 2, 2023. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 02:31 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 857 | $14.86 | $12,735.02 |
DisclosureSEC source: 0001627223-20-000012 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.